ReactWise Company Profile

Background

Overview

ReactWise is a London-based software company specializing in optimizing chemical processes within the pharmaceutical and chemical manufacturing industries. Founded in 2024 by Dr. Alexander Pomberger and Dr. Daniel Wigh, the company leverages artificial intelligence (AI) and machine learning to accelerate chemical process development, aiming to reduce the time and cost associated with bringing new drugs to market.

Mission and Vision

ReactWise's mission is to revolutionize chemical process development by equipping wet-lab chemists with data-driven optimization tools and robotic execution capabilities. The company's vision is to integrate AI-driven solutions into every laboratory, enhancing efficiency and innovation in drug manufacturing.

Primary Area of Focus

The company's primary focus is on chemical process optimization, utilizing AI to predict and identify optimal reaction conditions, thereby streamlining the development of pharmaceutical manufacturing processes.

Industry Significance

In an industry where process development often constitutes a significant bottleneck, ReactWise's technology offers a means to expedite the delivery of life-saving therapies, potentially reducing drug development timelines by up to 60%.

Key Strategic Focus

Core Objectives

Accelerate Chemical Process Development: Utilize AI to expedite the identification of optimal chemical reaction conditions, reducing the time required for process development.

Integrate Automation: Combine machine learning algorithms with robotic laboratory equipment to create self-driving labs that minimize manual intervention.

Specific Areas of Specialization

AI-Driven Optimization: Develop algorithms that leverage transfer learning and Bayesian optimization to enhance chemical process efficiency.

Robotic Laboratory Integration: Implement automated systems that interface with laboratory hardware to streamline experimental workflows.

Key Technologies Utilized

Machine Learning Algorithms: Employ advanced algorithms to model and predict chemical reactions.

Robotic Automation: Integrate with automated laboratory equipment to facilitate high-throughput experimentation.

Primary Markets Targeted

Pharmaceutical Industry: Assist in the rapid scaling of drug production by optimizing chemical processes.

Chemical Manufacturing: Enhance the efficiency of chemical production through data-driven process optimization.

Financials and Funding

Funding History

In March 2025, ReactWise raised $3.4 million in pre-seed funding. This round included investments from Y Combinator, Innovate UK, and other venture capitalists and angel investors.

Utilization of Capital

The funds are intended to support the expansion of ReactWise's AI models and automation platform, further developing their technology and supporting ongoing pilot studies with pharmaceutical companies.

Pipeline Development

Key Pipeline Candidates

ReactWise is currently conducting 12 pilot studies with major pharmaceutical companies to test and validate the effectiveness of its software in real-world applications.

Stages of Development

Pilot Studies: Ongoing collaborations with pharmaceutical companies to refine and validate the platform's capabilities.

Target Conditions

The focus is on optimizing chemical processes for small-molecule drugs, with potential applications in polymer drug delivery systems.

Anticipated Milestones

ReactWise aims to transition from pilot studies to full-scale deployments of its subscription-based software, with expectations for these conversions to occur later in 2025.

Technological Platform and Innovation

Proprietary Technologies

MemoryBO (Memory-Based Optimization): A transfer learning Bayesian optimization algorithm that pre-trains a probabilistic surrogate model on structured, domain-specific high-throughput experimentation data, enabling faster convergence in chemical process optimization.

Significant Scientific Methods

Bayesian Optimization: Utilized to actively learn about specific chemical processes, reducing the number of experiments needed to identify ideal process conditions.

Transfer Learning: Employed to leverage prior knowledge from similar chemical contexts, enhancing the efficiency of the optimization process.

AI-Driven Capabilities

Predictive Modeling: AI models trained on extensive chemical reaction data to predict optimal reaction conditions.

Automated Experimentation: Integration with robotic laboratory equipment to perform high-throughput experiments based on AI-driven predictions.

Leadership Team

Dr. Alexander Pomberger – CEO

Professional Background: Holds a PhD in chemical engineering and has been working at the intersection of machine learning, chemistry, and lab automation for the past five years.

Key Contributions: Developed optimization algorithms to aid in designing manufacturing processes for novel pharmaceuticals and co-founded ReactWise to democratize access to AI in pharma and biotech with no-code software.

Dr. Daniel Wigh – CTO

Professional Background: Holds a PhD in chemical engineering and has been working at the intersection of machine learning and chemistry for the past five years.

Key Contributions: Developed optimization algorithms to aid in designing manufacturing processes for novel pharmaceuticals and co-founded ReactWise to democratize access to AI in pharma and biotech with no-code software.

Competitor Profile

Market Insights and Dynamics

The pharmaceutical industry is experiencing a shift towards integrating AI and automation to streamline drug development processes. Companies are increasingly seeking solutions that can reduce the time and cost associated with bringing new drugs to market.

Competitor Analysis

Legacy Software Solutions: Traditional statistical software like JMP offers process optimization tools but may lack the advanced AI capabilities and high-quality datasets that ReactWise provides.

Other AI Startups: Several startups are applying AI to various aspects of drug development, but ReactWise distinguishes itself by focusing specifically on chemical process optimization and offering pretrained models that fundamentally understand chemistry.

Strategic Collaborations and Partnerships

ReactWise is engaged in pilot studies with major pharmaceutical companies, including some of the largest in the industry, to test and validate the effectiveness of its software in real-world applications.

Operational Insights

ReactWise's integration of AI with robotic laboratory equipment positions it uniquely in the market, offering a comprehensive solution that accelerates chemical process development and reduces reliance on traditional trial-and-error methods.

Strategic Opportunities and Future Directions

ReactWise aims to expand its platform's capabilities beyond reaction optimization, addressing the evolving needs of chemists in modern R&D environments. The company is also exploring applications in polymer drug delivery systems and other areas within the pharmaceutical and chemical manufacturing industries.